Ultimately, STAT1 transcriptionally activated PD-L1 and stability and exerted an immune associated function in pancreatic cancer, suggesting that PSMB8-AS1/miR-382–3p/STAT1/PD-L1 axis may act as a feasible therapeutic target for PC. The gene discussed is STAT1; the disease is pachyonychia congenita.